Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/34183385http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34183385http://www.w3.org/2000/01/rdf-schema#comment"

Background/aim

Peritoneal dissemination (PD) occurs frequently in gastric cancer (GC) and is fatal. The interactions between tumor cells and stromal cells are critical for cancer progression. Our aim was to identify a novel PD-associated gene derived from stromal cells in GC.

Materials and methods

Among the candidate PD-associated genes identified in our previous study, we focused on spondin-2 (SPON2), an extracellular matrix-secreted protein. Clinicopathological and prognostic analyses of SPON2 mRNA expression were performed using GC datasets. Localization of SPON2 expression was assessed by immunohistochemistry. In vitro migration assay and immunofluorescence staining were also conducted using GC cell lines.

Results

SPON2 was expressed in and secreted from cancer-associated fibroblasts in GC. High expression of SPON2 in tumor tissues was correlated with PD, tumor size and poor prognosis in GC. The motility of GC cells was increased by treatment with a SPON2 recombinant protein in vitro.

Conclusion

Cancer-associated fibroblast-derived SPON2 may promote PD, in part, by facilitating GC cell motility and serve as a predictive marker for PD in GC."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.org/dc/terms/identifier"doi:10.21873/cgp.20277"xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Abe T."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Kuramitsu S."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Hu Q."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Ito S."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Masuda T."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Mori M."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Mimori K."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Fujii A."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Oki E."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Yashiro M."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Otsu H."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Kitagawa A."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/author"Tobo T."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/name"Cancer Genomics Proteomics"xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/pages"521-529"xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/title"Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells."xsd:string
http://purl.uniprot.org/citations/34183385http://purl.uniprot.org/core/volume"18"xsd:string
http://purl.uniprot.org/citations/34183385http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34183385
http://purl.uniprot.org/citations/34183385http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/34183385
http://purl.uniprot.org/uniprot/#_Q9BUD6-mappedCitation-34183385http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34183385
http://purl.uniprot.org/uniprot/#_Q9H7I1-mappedCitation-34183385http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34183385
▶